Clinical and metabolic effects of a pill containing 30 mcg ethinylestradiol plus 75 mcg gestodene

This publication has 13 references indexed in Scilit:

• Fibrinopeptide a plasma levels during low-estrogen oral contraceptive treatment
  Contraception, 1984
• Pathophysiological Mechanisms of Estrogen Effect on Bone Metabolism. Dose-Response Relationships in Early Postmenopausal Women*
  Journal of Clinical Endocrinology & Metabolism, 1982
• Effects of progestogens on the cardiovascular system
  American Journal of Obstetrics and Gynecology, 1982
• The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins
  American Journal of Obstetrics and Gynecology, 1982
• Routine Liver Function Testing During Long Term Administration of the Oral Contraceptive Preparation 0.150 Mg Desogestrel Plus 0.030 Mg Ethinylestradiol to Healthy Female Volunteers in Scandinavia
  Published by Wiley ,1982
• Scandinavian Trial of an Oral Contraceptive Containing 0.150 Mg Desogestrel and 0.030 Mg Ethinylestradiol
  Published by Wiley ,1982
• Progestogen Effects and their Relationship to Lipoprotein Changes: A Report from the Oral Contraception Study of the Royal College of General Practitioners
  Acta Obstetricia et Gynecologica Scandinavica, 1982
• Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.
  BMJ, 1980
• ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENT
  The Lancet, 1980
• Ovulation Inhibition with Different Doses of Levonorgestrel and Other Progestogens: Clinical and Experimental Investigations
  Acta Obstetricia et Gynecologica Scandinavica, 1979